Albiflorin
CAS No. 39011-90-0
Albiflorin ( —— )
Catalog No. M18512 CAS No. 39011-90-0
Albiflorin and paeoniflorin has neuroprotective action against Glu toxicity.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | 342 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlbiflorin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlbiflorin and paeoniflorin has neuroprotective action against Glu toxicity.
-
DescriptionAlbiflorin has anticonvulsant effect for pain relief. Albiflorin and paeoniflorin has neuroprotective action against Glu toxicity. Albiflorin and paeoniflorin significantly ameliorated Glu-induced reduction of cell viability, nuclear and mitochondrial apoptotic alteration, reactive oxygen species accumulation and B-cell lymphoma 2 (Bcl-2)/Bax ratio. Albiflorin can serve as a new chemical marker for the quality control of Paeoniae Radix and the Chinese Pharmacopoeia can be updated, via has similar anti-inflammatory effects to paeoniflorin.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number39011-90-0
-
Formula Weight480.46
-
Molecular FormulaC23H28O11
-
Purity98%
-
SolubilityDMSO : ≥ 5.1 mg/mL; 10.61 mM
-
SMILESCC12CC(C3CC1(C3(C(=O)O2)COC(=O)C4=CC=CC=C4)OC5C(C(C(C(O5)CO)O)O)O)O
-
Chemical Name[1-(|A-d-glucopyranosyloxy)-4-hydroxy-6-methyl-8-oxo-7-oxatricyclo[4.3.0.03,9]non-9-yl]methyl benzoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Minimolide F
Minimolide F, isolated from Centipeda minima, shows antiproliferative activity against human nasopharyngeal cancer cells with an IC50 of 17.4 μM.
-
Luteolin-7-glucuroni...
Luteolin-7-Glucuronide possesses antioxidant activities.
-
Zolamide
Zolamide may be used to prevent altitude sickness and reduce the symptoms.